EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase

Petr Šlechta iD, Adam Anthony Needle, Ondřej Jand'ourek iD, Pavla Paterová iD, Klára Konečná iD, Pavel Bárta iD, Jiří Kuneš, Vladimír Kubíček, Martin Doležal iD, Marta Kučerová-Chlupáčová iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Petr Šlechta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové,…. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Anti-Infective Agents, Mycobacterium tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Czech Republic, Charles University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains a serious killer among infectious diseases due to its incidence, mortality, and occurrence of resistant mycobacterial strains. The challenge to discover new antimycobacterial agents forced us to prepare a series of N-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides 1–19 via the acylation of 6-aminobenzo[c][1,2]oxaborol-1(3H)-ol with various activated (hetero)arylcarboxylic acids. These novel compounds have been tested in vitro against a panel of clinically important fungi and bacteria, including mycobacteria. Some of the compounds inhibited the growth of mycobacteria in the range of micromolar concentrations and retained this activity also against multidrug-resistant clinical isolates. Half the maximal inhibitory concentrations against the HepG2 cell line indicated an acceptable toxicological profile. No growth inhibition of other bacteria and fungi demonstrated selectivity of the compounds against mycobacteria. The structure–activity relationships have been derived and supported with a molecular docking study, which confirmed a selectivity toward the potential target leucyl-tRNA synthetase without an impact on the human enzyme. The presented compounds can become important materials in antimycobacterial research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acyl-tRNA SynthetasesAnti-Infective AgentsMycobacterium tuberculosisHumansAnti-Bacterial AgentsAntitubercular AgentsFungiMicrobial Sensitivity TestsMolecular Docking SimulationStructure-Activity RelationshipAmides

Stichwörter der Autor:innen

antimicrobialantimycobacterialbenzoxaborolecytotoxicitymolecular dockingmultidrug-resistant tuberculosistuberculosis

Substanzen

Amino Acyl-tRNA SynthetasesAnti-Bacterial AgentsAnti-Infective AgentsAntitubercular AgentsAmides

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.
  • Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.
  • Department of Clinical Microbiology, University Hospital, 500 05 Hradec Králové, Czech Republic.
  • Department of Biophysics and Physical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.
  • Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.

ORCID-Profile: Petr Šlechta, Ondřej Jand'ourek, Pavla Paterová, Klára Konečná, Pavel Bárta, Martin Doležal, Marta Kučerová-Chlupáčová

Förderung

  • Ministry of Health of the Czech Republic
  • Charles University

Zitieren

APA

Šlechta, P., Needle, A. A., Jand'ourek, O., Paterová, P., Konečná, K., Bárta, P., Kuneš, J., Kubíček, V., Doležal, M., & Kučerová-Chlupáčová, M. (2023). Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032951

Vancouver

Šlechta P, Needle AA, Jand'ourek O, Paterová P, Konečná K, Bárta P, et al. Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032951

BibTeX
@article{lechta2023,
  author = {Šlechta, Petr and Needle, Adam Anthony and Jand'ourek, Ondřej and Paterová, Pavla and Konečná, Klára and Bárta, Pavel and Kuneš, Jiří and Kubíček, Vladimír and Doležal, Martin and Kučerová-Chlupáčová, Marta},
  title = {Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032951}
}
Kostenlos starten →